uniQure QURE
NASDAQ QURE
$44.50 -0.36 (-0.80%)
As of: Sep 4, 2026 · 3:59 PM EDT

uniQure (QURE) Amortizatization of Intangibles (2023 - 2026)

uniQure (QURE) posted quarterly Amortizatization of Intangibles of -$3.6 million for Q2 2026, down 74.58% year-over-year from -$14.1 million in Q2 2025, and up 17.6% quarter-over-quarter from -$4.3 million in Q1 2026.

Analysis

uniQure (QURE) Amortizatization of Intangibles (2023 - 2026) Analysis & Trends

uniQure's Amortizatization of Intangibles history runs 4 years deep, the most recent figure standing at -$3.6 million for Q2 2026.

  • In Q2 2026, Amortizatization of Intangibles fell 74.58% year-over-year to -$3.6 million; the TTM figure through Jun 2026 stood at -$14.2 million (down 69.29% YoY), while the FY2025 annual figure was -$10.5 million, up 4.02% from the prior year.
  • Amortizatization of Intangibles for Q2 2026 stood at -$3.6 million, up from -$4.3 million in the prior quarter.
  • The five-year high for Amortizatization of Intangibles was -$912000.0 in Q2 2023, with the low at -$4.7 million in Q3 2023.
  • The 4-year median for Amortizatization of Intangibles is -$2.7 million (2024), against an average of -$2.9 million.
  • Peak annual rise in Amortizatization of Intangibles reached 61.64% in 2024, while the deepest fall reached 299.46% in 2024.
  • uniQure's Amortizatization of Intangibles stood at -$4.4 million in 2023, then surged by 44.64% to -$2.4 million in 2024, then sank by 79.99% to -$4.4 million in 2025, then grew by 18.3% to -$3.6 million in 2026.
  • Business Quant data shows QURE's Amortizatization of Intangibles at -$3.6 million in Q2 2026, -$4.3 million in Q1 2026, and -$4.4 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - 4.33 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 678,000.00
10 uniQure 2.95 Bn 2.95 Bn 5.49 Mn -3.57 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -3.57 Mn
Mar 31, 2026 -4.34 Mn
Dec 31, 2025 -4.37 Mn
Sep 30, 2025 -1.93 Mn
Jun 30, 2025 -2.05 Mn
Mar 31, 2025 -2.12 Mn
Dec 31, 2024 -2.43 Mn
Sep 30, 2024 -1.80 Mn
Jun 30, 2024 -2.98 Mn
Mar 31, 2024 -3.70 Mn
Dec 31, 2023 -4.39 Mn
Sep 30, 2023 -4.69 Mn
Jun 30, 2023 -912,000.00
Mar 31, 2023 -925,000.00